RecruitingNCT06191965
MitoQ or placebo for cognition in early schizophrenia-spectrum conditions
About this title
Read the official source — NCT06191965Medication studyAges 18–35United States + Switzerland
Understand this study
Who could participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 35 years. Other eligibility criteria apply.
- Listed locations
- New Haven and 2 more locationsSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 1, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 100
- Sponsor
- Mclean Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States, Switzerland
- Age range
- From 18 Years to 35 Years
- Official registry ID
- NCT06191965
- Official title
Show the full official title
Double Blind, Randomized, Placebo-Controlled Study of MitoQ as Adjunctive Treatment for Patients With Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
New Haven, United States · Belmont, United States · Lausanne, Switzerland
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Mclean Hospital, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including MitoQ and Placebo.
Who can participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 35 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
